Susquehanna International Group
TBIO

Susquehanna International Group’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Susquehanna International Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-581
Closed -$6.45K – 13514
2023
Q3 		$10.9K Buy
+581
New +$14.1K ﹤0.01% 11710
2023
Q2 		– Sell
-2,354
Closed -$94K – 13409
2023
Q1 		$131K Buy
2,354
+1,535
+187% +$54.3K ﹤0.01% 11044
2022
Q4 		$18.4K Buy
+819
New +$22.3K ﹤0.01% 11789

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Susquehanna International Group's TBIO Position: Q4 2023 in Review

Susquehanna International Group sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q4 2023, closing a stake of 581 shares — an estimated $6.45K sold.

Susquehanna International Group first reported a position in TBIO in Q4 2022 and held it in 3 quarters. The position peaked at $131K in Q1 2023. 24 funds tracked by Wall St. Rank hold TBIO as of Q4 2023.

  • Susquehanna International Group reported no remaining Telesis Bio, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 581 Telesis Bio, Inc. Common Stock shares in Q4 2023, an estimated $6.45K.
  • Susquehanna International Group first reported a position in Telesis Bio, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Susquehanna International Group's Telesis Bio, Inc. Common Stock position peaked at $131K in Q1 2023.
  • 24 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.